UVLF Univerzitný portálUniverzita veterinárskeho lekárstva a farmácie v Košiciach
Slovenčina English

Hlavné menu

PublikáciePaclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies

Naspäť

Bibliografické údaje

Rok vydania
2018
Kategória
ADC — Vedecké práce v zahraničných karentovaných časopisoch
CREPČ / EPCA ID
0029865
Typ dokumentu
Článok z periodika
Zdroj
Molecular and Cellular Proteomics
ISSN (Zdroj)
1535-9476
Zväzok
Vol. 17, no. 6 (2018), p. 1126-1143
Jazyk
anglický
Študijný odbor
biológiaSkupina odborov: Prírodné vedy, matematika a informatika
Oblasti výskumu
130 — Vedy o živej prírode

Bibliografický zápis

DUHAMEL, Marie - ROSE, Mélanie - RODET, Franck - MURGOCI, Adriana - Natalia - ZOGRAFIDOU, Lea - RÉGNIER-VIGOUROUX, Anne - VANDEN ABEELE, Fabien - KOBEISSY, Firas - NATAF, Serge - PAYS, Laurent - WISZTORSKI, Maxence - ČÍŽKOVÁ, Dáša - FOURNIER, Isabelle - SALZET, Michel. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies [Liečba paklitaxelom a vylučovanie PC1/3 v makrofágoch je sľubnou stratégiou antigliómu, ako sa ukázalo v štúdiách proteomiky a cytotoxicity]. In: Molecular and Cellular Proteomics. 2018. ISSN 1535-9476, Vol. 17, no. 6 (2018), p. 1126-1143. (2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 2.305 - ABDC).

Autori publikácie

AutorRolaPodiel
Marie DuhamelAutor35.000 %
Mélanie RoseAutor5.000 %
Franck RodetAutor5.000 %
Adriana - Natalia MurgociAutor5.000 %
Lea ZografidouAutor5.000 %
Anne Régnier-VigourouxAutor5.000 %
Fabien Vanden AbeeleAutor5.000 %
Firas KobeissyAutor5.000 %
Serge NatafAutor5.000 %
Laurent PaysAutor5.000 %
Maxence WisztorskiAutor5.000 %
Dáša ČížkováAutor5.000 %
Isabelle FournierAutor5.000 %
Michel SalzetAutor5.000 %

Metriky

IF 4.828IF5 5.914SJR Q 1JCR Q 1SJR 2.807H-index 181ABDC 2.305Rok scientometrie 2018

Ohlasy (11)

Rok ohlasu / KategóriaOhlasyZdroj
2026
1

WIENER, Sophia Elisa - CONRAD, Jens - JAVID, Saman - GIESS, Sophie - JAGERSBERG, Max - KRENZLIN, Harald - KERIC, Naureen - REGNIER-VIGOUROUX, Anne - GEISS, Carsten. Generation of Heterotypic Primary Human Spheroids from Glioblastoma Resections and (Pre-)Clinical Applications. In CELLS, 2026, vol. 15, no. 11, pp. Dostupné na: https://doi.org/10.3390/cells15111021.

 WOS
2024
1

GAWEL, Agata M. - BETKOWSKA, Anna - GAJDA, Ewa - GODLEWSKA, Marlena - GAWEL, Damian. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment. In Biomedicines, 2024-08-01, 12, 8, pp. Dostupné na: https://doi.org/10.3390/biomedicines12081822.

 WoS + Scopus
2024
1

HUANG, Le - ZHAN, Jianhao - LI, Yao - HUANG, Kai - ZHU, Xingen - LI, Jingying. The roles of extracellular vesicles in gliomas: Challenge or opportunity? In Life Sciences, 2024-12-01, 358, pp. ISSN 00243205. Dostupné na: https://doi.org/10.1016/j.lfs.2024.123150.

 WOS
2024
1

MA, Tianfei - SU, Gang - WU, Qionghui - SHEN, Minghui - FENG, Xinli - ZHANG, Zhenchang. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression. In Molecular Biology Reports, 2024-12-01, 51, 1, pp. ISSN 03014851. Dostupné na: https://doi.org/10.1007/s11033-023-09196-5.

 WOS
2024
1

MOELLER, Jana - MEIER, Daniel T. Ablation of PC1/3 in POMC-Expressing Tissues but Not in Immune Cells Induces Sepsis Hypersensitivity. In Journal of the Endocrine Society, 2024-11-01, 8, 11, pp. Dostupné na: https://doi.org/10.1210/jendso/bvae171.

 WOS
2024
1

RAFFO-ROMERO, Antonella - ZIANE-CHAOUCHE, Lydia - SALOMÉ-DESNOULEZ, Sophie - HAJJAJI, Nawale - FOURNIER, Isabelle - SALZET, Michel - DUHAMEL, Marie. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses. In Cell Reports Methods, 2024-06-17, 4, 6, pp. Dostupné na: https://doi.org/10.1016/j.crmeth.2024.100792.

 WOS
2024
1

SU, Pengfei - LI, Ou - KE, Kun - JIANG, Zhichen - WU, Jianzhang - WANG, Yuanyu - MOU, Yiping - JIN, Weiwei. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review). In International Journal of Oncology, 2024-01-01, 64, 6, pp. ISSN 10196439. Dostupné na: https://doi.org/10.3892/ijo.2024.5648.

 WOS
2023
1

WENG, D.F. - HE, L. - CHEN, X.N. - LIN, H.F. - JI, D.H. - LU, S.T. - AO, L. - WANG, S.L. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, 2023, vol. 13, art. no. 1055412.

 WOS
2022
1

LU, Jianglong - XU, Fanjie - RAO, Changjun - SHEN, Chaodong - JIN, Jinghao - ZHU, Zhangzhang - WANG, Chengde - LI, Qun. Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. In FRONTIERS IN PHARMACOLOGY, 2022, vol. 13, no., pp. Dostupné na: https://doi.org/10.3389/fphar.2022.1076958.

 WOS
2019
1

LARIONOVA, Irina - CHERDYNTSEVA, Nadezhda - LIU, Tengfei - PATYSHEVA, Marina - RAKINA, Militsa - KZHYSHKOWSKA, Julia. Interaction of tumor-associated macrophages and cancer chemotherapy. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2019, vol. 8, no. 7, pp.

 WOS
2019
1

LI, Guoxiong - HUANG, Min - CAI, Yingqian - YANG, Yuantao - SUN, Xinlin - KE, Yiquan. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, 2019, vol. 234, no. 6, pp. 9144-9155.

 WoS